1. Home
  2. CPRX vs ACLS Comparison

CPRX vs ACLS Comparison

Compare CPRX & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • ACLS
  • Stock Information
  • Founded
  • CPRX 2002
  • ACLS 1995
  • Country
  • CPRX United States
  • ACLS United States
  • Employees
  • CPRX N/A
  • ACLS N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • ACLS Industrial Machinery/Components
  • Sector
  • CPRX Health Care
  • ACLS Technology
  • Exchange
  • CPRX Nasdaq
  • ACLS Nasdaq
  • Market Cap
  • CPRX 2.6B
  • ACLS 2.2B
  • IPO Year
  • CPRX 2006
  • ACLS 2000
  • Fundamental
  • Price
  • CPRX $20.59
  • ACLS $80.04
  • Analyst Decision
  • CPRX Strong Buy
  • ACLS Buy
  • Analyst Count
  • CPRX 5
  • ACLS 5
  • Target Price
  • CPRX $33.20
  • ACLS $90.00
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • ACLS 555.6K
  • Earning Date
  • CPRX 08-06-2025
  • ACLS 08-05-2025
  • Dividend Yield
  • CPRX N/A
  • ACLS N/A
  • EPS Growth
  • CPRX 183.96
  • ACLS N/A
  • EPS
  • CPRX 1.65
  • ACLS 4.91
  • Revenue
  • CPRX $558,499,000.00
  • ACLS $896,089,000.00
  • Revenue This Year
  • CPRX $16.51
  • ACLS N/A
  • Revenue Next Year
  • CPRX $9.58
  • ACLS $5.27
  • P/E Ratio
  • CPRX $12.45
  • ACLS $16.31
  • Revenue Growth
  • CPRX 28.55
  • ACLS N/A
  • 52 Week Low
  • CPRX $19.00
  • ACLS $40.40
  • 52 Week High
  • CPRX $26.58
  • ACLS $113.37
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 48.79
  • ACLS 54.35
  • Support Level
  • CPRX $19.83
  • ACLS $79.78
  • Resistance Level
  • CPRX $21.82
  • ACLS $82.77
  • Average True Range (ATR)
  • CPRX 0.57
  • ACLS 2.71
  • MACD
  • CPRX 0.07
  • ACLS -0.26
  • Stochastic Oscillator
  • CPRX 45.33
  • ACLS 30.19

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Share on Social Networks: